Post-stroke attention deficit
Conditions
Interventions
rTMS Group:High?frequency rTMS (real stimulation) + blank music (no music)
Combined Group:Music therapy + high-frequency rTMS (real stimulation)
Conventional Rehabilitation Group:Conventional rehabilitation + rTMS sham stimulation + blank music (no music)
Music Therapy Group:Music therapy + rTMS sham stimulation
Sponsors
The Second Affiliated Hospital of Hainan Medical University
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. First-ever stroke, meeting the diagnostic criteria for stroke as defined in the Chinese Diagnostic Criteria for Major Cerebrovascular Diseases (2019 Edition); 2. Age between 45 and 75 years, right-handed; 3. Subacute phase within 6 months of onset, with >=1 week for ischemic stroke and >=2 weeks for hemorrhagic stroke; 4. Montreal Cognitive Assessment (MoCA) score < 26, with an attention subscore <= 4; 5. Stable vital signs, conscious and alert, able to cooperate with assessments and interventions; 6. Patient or a family member voluntarily signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Presence of any contraindication to rTMS: non-removable metal implants (e.g., aneurysm clips, stents), implanted cardiac pacemaker, history of epilepsy or EEG findings indicative of epileptiform discharges, or increased intracranial pressure; 2.Prior history of stroke or other neurological disorders that may affect cognitive function (e.g., Alzheimer’s disease, Parkinson’s disease, intracranial tumor, traumatic brain injury); 3.Severe visual or auditory impairment that precludes effective participation in music therapy or completion of neuropsychological assessments; 4.Severe comorbid systemic diseases involving the heart, lungs, liver, kidneys, or malignant tumors; 5.History of psychiatric illness, personality disorder, or alcohol/substance abuse; 6.Skin lesion or inflammation at the stimulation site that prevents placement of the rTMS coil; 7.Current participation in another interventional clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TMT-A; | — |
Secondary
| Measure | Time frame |
|---|---|
| Stroke-Specific Quality of Life Scale (SS-QOL);qEEG;MoCA;TMT-B; | — |
Countries
China
Contacts
Public ContactYao Bonuan
The Second Affiliated Hospital of Hainan Medical University
Outcome results
None listed